Tighter Drug-Discount Rules Loom After 340B Report
A new inspector general's report is handing drugmakers fresh ammunition to argue that hospitals and clinics are abusing a multibillion-dollar drug-discount program known as 340B, putting pressure on the Obama administration...To view the full article, register now.
Already a subscriber? Click here to view full article